Tara Lin

University of Kansas Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (9)

Fieke Hoff

University of Texas Southwestern Medical Center

UNITED STATES

View details

Shelley Orwick

Ohio State University

UNITED STATES

View details

Mitch Phelps

Ohio State University

UNITED STATES

View details

Pamela Becker

Professor of Clinical Medicine

University of California, Irvine

UNITED STATES

View details

Eric Eisenmann

Ohio State University

UNITED STATES

View details

Yazan F. Madanat

UNITED STATES

View details

Stephen Strickland

Assistant Professor of Medicine

Vanderbilt University Medical Center

UNITED STATES

View details

Danny Welch

Professor and Founding Chair

University of Kansas Medical Center

UNITED STATES

View details

Amer M. Zeidan

Yale University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tara Lin

Research Interests

Explore related searches

Contact this professor

Articles (10)

A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years

V-FAST: a phase 1b master trial to investigate CPX-351 combined with targeted agents in adults with newly diagnosed AML

Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia

Are you ready for it? VEN-HMA for younger patients with AML

Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

Beat-AML 2024 ELN-Refined Risk Stratification for Older Adults with Newly Diagnosed AML Given Lower-Intensity Therapy

Bolstering the complex study start-up process at NCI cancer centers using technology

Preclinical Evaluation of Gilteritinib on NPM1-ALK–Driven Anaplastic Large Cell Lymphoma Cells

A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of HOXA9 and MEIS1 Expression

Collaborators (9)

Fieke Hoff

Shelley Orwick

Mitch Phelps

Pamela Becker

Eric Eisenmann

Yazan F. Madanat

Stephen Strickland

Danny Welch

Amer M. Zeidan

Make your next move.